!!Carlo Patrono - Curriculum vitae
\\						
__EDUCATION:__
\\
*1962 B.S, Arts, Liceo Classico Nazareno; Rome, Italy
*1968 M.D.Cum Laude Catholic University School of Medicine, Rome, Italy
*1969-1971 Postdoctoral Fellow Medicine Bronx Veterans Administration, Hospital and Mount Sinai, School of Medicine, New York, U.S.A.
\\
__PROFESSIONAL EXPERIENCE:__
\\
*1972-1982 Assistant Professor, Department of  Pharmacology, Catholic University School of Medicine, Rome
*1983-1985 Associate Professor, Department of  Pharmacology Catholic University School of Medicine, Rome
*1984-1985 Lecturer in Medicine, Mount Sinai School of  Medicine, New York, USA
*1985-1986 Visiting Professor, Department of Pharmacology, King's College, London, Departments of Medicine (Cardiovascular Unit) and Clinical Pharmacology, Royal Postgraduate Medical School London, U.K.
*1991-2001 Professor of Pharmacology University of Chieti, "G. D'Annunzio" School of Medicine
*1996-1997 Visiting Professor of University of  Pennsylvania Pharmacology School of Medicine, Philadelphia, USA
*2001- Director,  MIUR Center of “G. D’Annunzio” University Excellence on Aging Foundation, Chieti
*2001-2006 Professor of Pharmacology University of  Rome “La Sapienza” 2nd School of Medicine
*2007- Professor and Chair of Pharmacology  Catholic University School of Medicine, Rome
\\
__PROFESSIONAL & SCIENTIFIC MEMBERSHIPS:__
\\
*Member of the Italian Society of Pharmacology, 1968-
*Founding Member, Association for Patient-Oriented Research
*Member of the Council on Arteriosclerosis, Thrombosis, and Vascular Biology of the American Heart Association
*Honorary Member of the Association of American Physicians, 1991-
*Fellow of the European Society of Cardiology, 1994-
*Member of the Council on Thrombosis of the International Society and Federation of Cardiology, 1994-1996
*Chairman, Working Group "Thrombosis and Platelets" of the European Society of Cardiology, 1994-1996
*Member of the Advisory Committee of the General Clinical Research Center, University of Pennsylvania, 1996-1997
*Member of the Cardiovascular Review Committee, Commission of the European Communities, BIOMED Programme, 1997
*Fellow of the Royal College of Physicians in Ireland, 1998-
*Chairman, Task Force on Antithrombotic Agents of the European Society of Cardiology, 2000-2003 and 2009-
*External Advisor, NIH Center in Pharmacology, Vanderbilt University School of Medicine, Nashville, TN, 2000-
*Chair, International COX-2 Study Group, 2002-2005
*Fellow of the Royal College of Physicians, 2003-
*Member of Academia Europaea, 2004-
*Member of Accademia Nazionale dei Lincei, 2004-
\\
__AWARDS and HONORS:__
\\
*1980:	Alexander B. Gutman Visiting Professorship of Medicine, awarded by the Mount Sinai School of Medicine, New York
*1981:	Upjohn Award "Excellence in Pharmacology" of the Italian Society of Pharmacology
*1982:	W.N. Creasy Visiting Professorship of Clinical Pharmacology, awarded by the Burroughs Wellcome Fund
*1985:	Senior Fellowship, awarded by the British Council
*1998:   International Aspirin® Senior Award, awarded by Bayer AG
*2007:   John Vane Award of the University of London
\\
__EDITORIAL ACTIVITIES:__
\\
*Co-Editor of  7  books and journal issues (see list of publications).
*Member of the Editorial Board of Clinical and Experimental Rheumatology (1982-present)
*Member of the Editorial Board of the European Journal of Clinical Pharmacology (1984-2007)
*Member of the Editorial Board of Trends in Cardiovascular Medicine (1990-1995)
*Field Editor (Cardiovascular Pharmacology) of Pharmacological Research (1999-2008)
*Member of the Editorial Board of Circulation (2000-present)
*Member of the Editorial Board of Arteriosclerosis, Thrombosis and Vascular Biology (2002-present)
*Member of the Editorial Advisory Board of Molecular Interventions, (2005-present)
\\
__CURRENTLY FUNDED RESEARCH PROJECTS:__
\\
#European Commission, 6th Framework Programme, EICOSANOX “Eicosanoids and Nitric Oxide: Mediators of Cardiovascular, Cerebral & Neoplastic Diseases” 2005-2009 (Cluster Leader and Member of the Project Steering Committee)
#“Antiplatelet Effects of a 12-hour Dosing Interval of Low-Dose Aspirin Administration in Patients with Type  2 Diabetes Mellitus and Enhanced Platelet Turnover” (2008-2010), funded by Bayer HealthCare AG (Principal Investigator)
#“A Longitudinal Study of the Time-Course of Platelet Activation During the Development and Progression of Type 2 Diabetes Mellitus” (2009-2011), funded by Bayer HealthCare AG (Principal Investigator)
#Innovative Medicines Initiative “Surrogate markers for micro- and macro-vascular hard endpoints for innovative diabetes tools (SUMMIT)” (2009-2013) Co-Investigator
\\
__CURRENT INSTITUTIONAL ACTIVITIES:__
\\
*Member of Consiglio Direttivo, Centro di Scienze dell’Invecchiamento, Fondazione Università “G. d’Annunzio”
*Member of the Ethics Committee, Catholic University School of Medicine, Rome
*Chair of the Drug Therapy Committee, Catholic University School of Medicine, Rome.